The latest closing stock price for Iterum Therapeutics as of September 18, 2024 is 1.09.
An investor who bought $1,000 worth of Iterum Therapeutics stock at the IPO in 2018 would have $-994 today, roughly -1 times their original investment - a -57.79% compound annual growth rate over 6 years.
The all-time high Iterum Therapeutics stock closing price was 192.75 on May 25, 2018.
The Iterum Therapeutics 52-week high stock price is 2.50, which is 129.4% above the current share price.
The Iterum Therapeutics 52-week low stock price is 0.62, which is 43.1% below the current share price.
The average Iterum Therapeutics stock price for the last 52 weeks is 1.37.
An investor who bought $1,000 worth of Iterum Therapeutics stock at the IPO in 2018 would have $-994 today, roughly -1 times their original investment - a -57.79% compound annual growth rate over 6 years.
The all-time high Iterum Therapeutics stock closing price was 192.75 on May 25, 2018.
The Iterum Therapeutics 52-week high stock price is 2.50, which is 129.4% above the current share price.
The Iterum Therapeutics 52-week low stock price is 0.62, which is 43.1% below the current share price.
The average Iterum Therapeutics stock price for the last 52 weeks is 1.37.